+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Jardiance"

From
Diabetic Gastroparesis Treatment Market Report 2025 - Product Thumbnail Image

Diabetic Gastroparesis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Empagliflozin, Dapagliflozin and Canagliflozin Market Report 2024 - Product Thumbnail Image

Empagliflozin, Dapagliflozin and Canagliflozin Market Report 2024

  • Report
  • September 2024
  • 175 Pages
  • Global
From
From
From
JARDIANCE Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

JARDIANCE Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
Anti-diabetic Drugs Market - Product Thumbnail Image

Anti-diabetic Drugs Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
From
From
From
From
Loading Indicator

Jardiance is a medication used to treat type 2 diabetes, a condition in which the body does not produce enough insulin or does not use insulin properly. It belongs to a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, which work by blocking the reabsorption of glucose in the kidneys, allowing it to be excreted in the urine. This helps to lower blood sugar levels. Jardiance is typically used in combination with other diabetes medications, such as metformin, to help control blood sugar levels. Jardiance is part of a larger market of endocrine and metabolic disorder drugs, which includes medications used to treat conditions such as obesity, thyroid disorders, and polycystic ovary syndrome. These drugs are used to help regulate hormones and metabolism, and can help to improve overall health and quality of life. Companies in the Jardiance market include Boehringer Ingelheim, Merck, and Eli Lilly. Show Less Read more